UJenaValve Uchonga uKari Moore njengeGosa eliyiNtloko lezeMali

IRVINE, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc. ("iJenaValve okanye "iNkampani"), umphuhlisi kunye nomvelisi weenkqubo ezahlukeneyo ze-transcatheter aortic valve replacement (TAVR) , namhlanje ubhengeze ukuqeshwa kwe UKari Moore njengeGosa lezeMali eliyiNtloko lenkampani elisebenza nge-10 kaMeyi, 2022. "Siyavuya ukwamkela uKari kwiqela leJenaValve," utshilo umphathi weJenaValve uJohn Kilcoyne." UKari uneminyaka engaphezu kwe-35 yamava abanzi emali kunye nokusebenza kwisixhobo sonyango kunye amashishini ezempilo. Ulwazi oluphangaleleyo lukaKari kunye nobuchule boshishino buza kusinceda siqhubeleke sisebenzisa isicwangciso sethu sonyango kwaye siqhubele phambili iTrilogy yethu yonyango lwesifo se-aortic valve ® Iinzame zoRhwebo kwiiNkqubo zeValve yeNtliziyo. UNksz Moore ujoyina i-JenaValve emva kokusebenza njengeGosa eliPhezulu loCwangciso-mali kwi-Envista Holdings Corporation, inkampani yehlabathi yeemveliso zamazinyo, apho wayenoxanduva lwe-accounting yehlabathi, imali kunye nemisebenzi yeenkonzo ekwabelwana ngazo.Ngaphambi kokujoyina i-Envista Holdings Corporation, uNksz Moore wayeyiNtloko IGosa eliNika iNgxelo le-Applied Medical Corporation, inkampani yezixhobo zonyango yehlabathi jikelele ebonelela ngobuchwepheshe kunye nezisombululo zotyando olungephi kunye nolwenze jikelele. UMoore waqala ukusebenza ePricewaterhouseCoopers, apho wayesebenza njengeqabane lophicotho-zincwadi, esebenza ngokukhethekileyo kwishishini lezenzululwazi zobomi. Ngexesha lomsebenzi wakhe weminyaka engama-20, uNksz. Moore uthathe iinkampani ezininzi esidlangalaleni kwaye wazincedisa ekufumaneni, ekukhupheni nasekukhupheni amatyala. UKari ubambe. iBA kuLawulo lwezoShishino evela kwiDyunivesithi yaseMazantsi eCalifornia kwaye yiCPA kwiphondo laseCalifornia. “Kuyandivuyisa ukujoyina iJenaValve ngexesha elinzima kangaka,” utshilo uNksz Moore. "Ndivuyiswe ukusebenza kunye neqela lonke leJenaValve njengoko siqhubeka siqhuba ekukhuleni kwethu kunye nezicwangciso zokudala ixabiso ngelixa siphucula ubomi bezigulane." Malunga neJenaValve JenaValve Technology, Inc., enekomkhulu e-Irvine, eCalifornia, eneendawo eLeeds, e-UK naseMunich, eJamani, iphuhlisa kwaye ivelise iinkqubo ze-transcatheter aortic valve replacement (TAVR) zonyango lwezigulane ezine-aortic valve disease.JenaValve ixhaswa yi I-Bain Capital Life Sciences kunye ne-Cormorant Asset Management, kunye nabatyali-mali baseYurophu nabase-Asia kuquka i-Andera Partners, i-Gimv (i-Euronext: i-GIMB), i-Legend Capital, i-NeoMed Management, i-RMM, i-Valiance Life Sciences, i-VI Partners kunye ne-Peijia Medical Limited (HKEx: 9996) . EUnited States: Ingqalelo-Izixhobo zoPhando.Ithintelwe ngumthetho womanyano (okanye wase-US) wokusetyenziswa kophando kuphela.